Salarius Pharmaceuticals Announces Planned Corporate Name and Ticker Symbol Change to Decoy Therapeutics, Reflecting Strategic Pivot to Next-Generation Antiviral and Peptide-Conjugate Platform GlobeNewswire December 18, 2025 The combined Company will move forward as Decoy Therapeutics, Inc. and trade on the NASDAQ Stock Market under the ticker “DCOY” effective in early January 2026 Company to focus […]

Hardy Diagnostics, a leading manufacturer and distributor of culture media and diagnostic solutions for microbiology laboratories, proudly announces its strategic partnership with NEMIS Technologies, a Swiss-based innovator in rapid on-site pathogen detection. Through this exclusive collaboration, Hardy Diagnostics will introduce NEMIS's cutting-edge N-Light™ technology and advanced hygiene monitoring solutions to the North American market. https://mma.prnewswire.com/media/2848321/Hardy_Diagnostics_3005_COS_Official_Logo_Logo.jpg

NEW YORK, NY / ACCESS Newswire / December 18, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding Telix Pharmaceuticals Ltd. (NASDAQ:TLX) class action securities lawsuit A Class Action lawsuit was filed on behalf of Telix Pharmaceuticals Ltd. investors who lost money as a result of alleged securities fraud between February 21, 2025 and

(TSX:MBX),(OTC US:MBXBF),(Other OTC:MBXBF), MISSISSAUGA, Ontario, Dec. 18, 2025 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix(R)), a life sciences innovator, manufacturer, and exporter, reports results for its fiscal year and fourth quarter ended September 30, 2025 (“2025” and “Q4“) with revenues for those periods reflecting reduced antigen sales into China and cancellation

Microbix Reports Results for Q4 and Fiscal 2025 Full-Year Revenues of $18.6 million and Net Loss of $2.2 million GlobeNewswire December 18, 2025 MISSISSAUGA, Ontario, Dec. 18, 2025 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix(R)), a life sciences innovator, manufacturer, and exporter, reports results for its fiscal year and fourth quarter

NEW YORK, NY / ACCESS Newswire / December 18, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding Stride, Inc. (NYSE:LRN) class action securities lawsuit A Class Action lawsuit was filed on behalf of Stride, Inc. investors who lost money as a result of alleged securities fraud between October 22, 2024 and October 28,

Option to support charitable donations help spread holiday cheer at every checkout Oracle Payments now available in Canada and new US venues Oracle is enhancing how hospitality brands engage with guests and manage their operations, with new Oracle Paymentsfeatures such as in-terminal charitable donations, expanded device offerings, and new location and regional coverage. These updates

AtkinsRéalis Group Inc. (TSX: ATRL), a world-class engineering services and nuclear company with offices around the world, has been appointed by Network Rail, Britain's rail infrastructure owner, to design and develop the Midlands Rail Hub program, which will transform rail connectivity across Birmingham and the West Midlands region. AtkinsRéalis will form part of an alliance

NEW YORK, NY / ACCESS Newswire / December 18, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding DexCom, Inc. (NASDAQ:DXCM) class action securities lawsuit A Class Action lawsuit was filed on behalf of DexCom, Inc. investors who lost money as a result of alleged securities fraud between January 8, 2024 and September 17,

NEW YORK, NY / ACCESS Newswire / December 18, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding Firefly Aerospace Inc. (NASDAQ:FLY) class action securities lawsuit This lawsuit is on behalf of a class consisting of all persons and entities other than defendants that purchased or otherwise acquired: (a) Firefly common stock pursuant and/or